There Are No COVID Vaccines Targeting Variants — and That Should Terrify Us

We need a portfolio of new vaccines ready to go in as little as 100 days. But Big Pharma is too slow and profit-hungry to get the job done.

Related Keywords

Germany ,China ,South Africa ,United States ,Wuhan ,Hubei ,Chinese ,German ,Martin Friede ,Barney Graham ,William Gruber ,Anthony Fauci ,Craig Garthwaite ,James Hildreth ,Eric Rubin ,Nicole Lurie ,Rena Conti ,Petro Terblanche ,International Monetary Fund ,National Institute Of Allergy ,Coalition For Epidemic Preparedness Innovations ,Pfizer ,Astrazeneca ,Oxford University ,Vaccine Research Center ,National Institutes Of Health ,Biomedical Advanced Research ,Drug Administration ,World Health Organization ,Development Authority ,Boston University Institute For Health System Innovation ,University Of Pennsylvania ,National Bureau Of Economic Research ,Defense Department ,Northwestern University ,Big Pharma ,National Bureau ,Economic Research ,National Institutes ,National Institute ,Drew Weissman ,Boston University ,Health System Innovation ,World Health ,Epidemic Preparedness ,Coronavirus ,Covid 19 Vaccine ,Moderna ,Public Health ,Bi Prime ,Vicky Leta ,I Graphics ,Hilary Brueck ,